Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Diabetic Medicine : a Journal of the British Diabetic Association|June 30, 2019
Pharmacological treatment for Type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UKS C Bain, A Bakhai, M Evans, et al.
QJM : Monthly Journal of the Association of Physicians|September 17, 2011
The management of diabetes in terminal illness related to cancerE J King, H Haboubi, D Evans, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 19, 1998
Factors associated with clinic non-attendance in adults with type 1 diabetes mellitusP H Dyer, C E Lloyd, R J Lancashire, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 12, 2011
Impact of pre-exercise rapid-acting insulin reductions on ketogenesis following running in Type 1 diabetesR M Bracken, D J West, J W Stephens, et al.
Diabetes & Metabolism|October 2, 2012
Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetesJ Vora, S C Bain, T Damci, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 17, 2018
A retrospective observational study of people with Type 1 diabetes with self-reported severe hypoglycaemia reveals high level of ambulance attendance but low levels of therapy change and specialist interventionB C T Field, R Nayar, A Kilvert, et al.
Diabetologia|July 1, 1997
A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturity-onset diabetes of the youngM P Bulman, M J Dronsfield, T Frayling, et al.
Diabetologia|September 24, 1999
Human leucocyte antigen and insulin gene regions and nephropathy in type I diabetesT A Chowdhury, P H Dyer, C H Mijovic, et al.
Human Molecular Genetics|October 9, 2001
A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteinsF Cucca, R Lampis, M Congia, et al.
Clinical Chemistry|July 1, 1991
Detection of human apolipoprotein E3, E2, and E4 genotypes by an allele-specific oligonucleotide-primed polymerase chain reaction assay: development and validationE K Green, S C Bain, P J Day, et al.
Pageof 7